Hypoxia pathway and hypoxia-mediated extensive extramedullary hematopoiesis are involved in ursolic acid's anti-metastatic effect in 4T1 tumor bearing mice
暂无分享,去创建一个
T. He | Qiyang Shou | Jian-Li Gao | Xin Ji | Bai-Cheng He | Wei Jiang | Enyi Huang | Guiyuan Lv | Yan-Mei Shui
[1] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[2] B. Aggarwal,et al. Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment , 2016, Oncotarget.
[3] Qi Zhang,et al. Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model. , 2015, Oncology letters.
[4] L. Pan,et al. Macrophages Support Splenic Erythropoiesis in 4T1 Tumor-Bearing Mice , 2015, PloS one.
[5] Jingwei Shao,et al. A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis , 2015, Oncotarget.
[6] B. Nelson,et al. Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells. , 2013, Cancer research.
[7] David Jou,et al. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3. , 2013, Anticancer research.
[8] S. Ahn,et al. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. , 2013, Cancer letters.
[9] A. Bishayee,et al. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. , 2013, Biochemical pharmacology.
[10] Xiaoyi Xu,et al. Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression in T24 human bladder cancer cells. , 2013, Molecular medicine reports.
[11] T. He,et al. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways , 2013, Oncology reports.
[12] K. Kristiansen,et al. Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. , 2013, The Journal of nutritional biochemistry.
[13] M. Gassmann,et al. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. , 2013, Blood.
[14] Hongbo Hu,et al. Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells , 2013, Autophagy.
[15] Chuanlu Jiang,et al. Ursolic Acid Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Cell Lines U251 by Suppressing TGF‐β1/miR‐21/PDCD4 Pathway , 2012, Basic & clinical pharmacology & toxicology.
[16] V. Baladandayuthapani,et al. Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine , 2012, Clinical Cancer Research.
[17] Tao Xi,et al. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells , 2012, Medical Oncology.
[18] Chun-Yin Huang,et al. Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[19] G. Sethi,et al. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice , 2011, Journal of Molecular Medicine.
[20] T. He,et al. Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer , 2011, Molecular Pharmacology.
[21] T. He,et al. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. , 2011, International journal of oncology.
[22] T. He,et al. Lysophosphatidic Acid Acyltransferase β (LPAATβ) Promotes the Tumor Growth of Human Osteosarcoma , 2010, PloS one.
[23] S. Perkins,et al. Antitumor Effects of Ursolic Acid in a Mouse Model of Postmenopausal Breast Cancer , 2010, Nutrition and cancer.
[24] G. Qin,et al. e0049 E2F1 stabilises p53 to suppress VEGF expression and neovascularization in the ischaemic myocardium , 2010, Heart.
[25] T. He,et al. Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells , 2010, PloS one.
[26] T. He,et al. Insulin-like Growth Factor 2 (IGF-2) Potentiates BMP-9-Induced Osteogenic Differentiation and Bone Formation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] Gow-Chin Yen,et al. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. , 2010, Journal of agricultural and food chemistry.
[28] T. He,et al. Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma , 2010, Clinical Cancer Research.
[29] Yu Zeng,et al. Ursolic acid induces PC‐3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro , 2010, Molecular carcinogenesis.
[30] Xianghong Wang,et al. Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells , 2009, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[31] Yihai Cao,et al. Tumor-derived VEGF modulates hematopoiesis , 2009, Journal of angiogenesis research.
[32] T. He,et al. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. , 2009, Differentiation; research in biological diversity.
[33] T. He,et al. A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity. , 2009, Oncology reports.
[34] D. Ginsberg,et al. p53 and E2f: partners in life and death , 2009, Nature Reviews Cancer.
[35] T. He,et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.
[36] J. Shay,et al. In vivo and in vitro effects of a HIF‐1α inhibitor, RX‐0047 , 2008, Journal of cellular biochemistry.
[37] W. Rathmell,et al. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. , 2007, The Journal of clinical investigation.
[38] D. Redelman,et al. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci , 2007, International journal of experimental pathology.
[39] B. Aggarwal,et al. Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells , 2007, Molecular Cancer Research.
[40] Wei Jiang,et al. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. , 2007, Gene.
[41] K. Kinzler,et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.
[42] R. Hill,et al. Hypoxia and Metastasis , 2007, Clinical Cancer Research.
[43] G. Amin,et al. Chemical Constituents of Dichloromethane Extract of Cultivated Satureja khuzistanica , 2006, Evidence-based complementary and alternative medicine : eCAM.
[44] F. Martelli,et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[45] H. Clevers,et al. Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis , 2006, Oncogene.
[46] Herman Yeger,et al. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. , 2005, Cancer research.
[47] G. Semenza. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.
[48] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[49] A. Jemal,et al. Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.
[50] Pingchaun Li,et al. Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells. , 2013, Cellular signalling.
[51] A. Bishayee,et al. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. , 2011, Frontiers in bioscience.
[52] Qing-Wen Zhang,et al. Angiogenic pathway inhibition of Corydalis yanhusuo and berberine in human umbilical vein endothelial cells. , 2009, Oncology research.
[53] Qing-Wen Zhang,et al. Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways. , 2008, Oncology reports.
[54] A. Jemal,et al. Breast Cancer Statistics , 2013 .
[55] C. Hagen,et al. Insulinlike Growth Factor Binding Proteins , 1990 .
[56] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.